We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
- Authors
O'Connor, Erin S; Greenblatt, David Yu; LoConte, Noelle K; Gangnon, Ronald E; Liou, Jinn-Ing; Heise, Charles P; Smith, Maureen A
- Abstract
Adjuvant chemotherapy is typically considered for patients with stage II colon cancer characterized by poor prognostic features, including obstruction, perforation, emergent admission, T4 stage, resection of fewer than 12 lymph nodes, and poor histology. Despite frequent use, the survival advantage conferred on patients with stage II disease by chemotherapy is yet unproven. We sought to determine the overall survival benefit of chemotherapy among patients with stage II colon cancer having poor prognostic features.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 25, p3381
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.34.3426